More Speakers will be added soon

Executive Keynote Speakers:

David MEEK

David MEEK

David MEEK joined Ipsen as CEO in July 2016. He holds a BA in Management from the University of Cincinnati and started his career at Johnson & Johnson and Janssen Pharmaceutica (1989-2004).

More Expert Panel Speakers to be announced soon:

Dr Shahin GHARAKHANIAN

Dr Shahin GHARAKHANIAN

Dr Shahin Gharakhanian is the founder of the 1st Boston-Paris Biotechnology Summit. Shahin specializes in Drug & Vaccine Clinical Development Medical Affairs.

Patrick TRICOLI

Patrick TRICOLI

Patrick focused on neuropharmacology research in academia/industry, both in France and US (1986-1990) then Synthélabo Recherche in 1991.

Julius STEFFEN

Julius STEFFEN

Julius is a Senior Consultant at Bionest Partners in Paris. Prior to joining Bionest in 2016, Julius worked for 6 years in the healthcare sector, both on the consulting and industry side.

Dr Joseph F. Merola

Dr Joseph F. Merola

Joseph F. Merola, MD, MMSc, is Assistant Professor in the Department of Dermatology and Department of Medicine, Division of Rheumatology at Harvard Medical School in Boston, Massachusetts.

Mark A. De Rosch

Mark A. De Rosch

Mark A. De Rosch, PhD, FRAPS, was formarly Senior Vice President of Regulatory Affairs, Quality Assurance, and CMC at Akebia Therapeutics, Inc.

Camilla S. Graham

Camilla S. Graham

Cami Graham, MD, MPH is the VP of Corporate and Medical Affairs at Trek Therapeutics, Co-Director of the Viral Hepatitis Center in the Division of Infectious Disease at Beth Israel Deaconess Medical Center and an Assistant Professor of Medicine at Harvard Medical School in Boston, Massachusetts.

Chairpersons:

Professor Kenneth I Kaitin, PhD

Professor Kenneth I Kaitin, PhD

Kenneth Kaitin is Professor of Medicine at Tufts University School of Medicine and Director of the Tufts Center for the Study of Drug Development

Pravin R. Chaturverdi, Ph.D.

Pravin R. Chaturverdi, Ph.D.

Dr. Pravin Chaturvedi is the Chairman of the Scientific Advisory Board for Napo Pharmaceuticals and is the CEO for IndUS and Oceanyx Pharmaceuticals.